China Universal Asset Management Company’s United Therapeutics UTHR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.61M	Buy	7,778 +262	+3%	+$130K	0.35%	58
2025 Q4	$3.66M	Sell	7,516 -2,411	-24%	-$1.12M	0.28%	64
2025 Q3	$4.16M	Buy	9,927 +868	+10%	+$292K	0.34%	61
2025 Q2	$2.6M	Buy	9,059 +50	+0.6%	+$14.9K	0.24%	86
2025 Q1	$2.78M	Sell	9,009 -457	-5%	-$157K	0.26%	83
2024 Q4	$3.34M	Buy	9,466 +909	+11%	+$334K	0.31%	68
2024 Q3	$3.07M	Buy	8,557 +3,344	+64%	+$1.13M	0.34%	64
2024 Q2	$1.66M	Sell	5,213 -3,827	-42%	-$1.01M	0.23%	80
2024 Q1	$2.08M	Buy	9,040 +3,603	+66%	+$813K	0.26%	80
2023 Q4	$1.2M	Buy	5,437 +4,240	+354%	+$977K	0.23%	95
2023 Q3	$270K	Buy	1,197 +582	+95%	+$134K	0.08%	131
2023 Q2	$136K	Sell	615 -13	-2%	-$2.88K	0.04%	146
2023 Q1	$141K	Buy	628 +165	+36%	+$40.7K	0.05%	124
2022 Q4	$129K	Buy	463 +37	+9%	+$9.34K	0.05%	115
2022 Q3	$89K	Buy	+426	New	+$95.2K	0.04%	114